Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial

BACKGROUD: The European Organization for Research and Treatment of Cancer (EORTC) trial 22,911 reported 74% 5-year biochemical disease-free survival (bDFS) in patients with prostate carcinoma treated with radical prostatectomy (RP) followed by postoperative radiotherapy (RT). This study aimed to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantini, Giovanna, Siepe, Giambattista, Alitto, Anna Rita, Buwenge, Milly, Nguyen, Nam P., Farioli, Andrea, Schiavina, Riccardo, Catucci, Francesco, Deodato, Francesco, Fionda, Bruno, Frascino, Vincenzo, Macchia, Gabriella, Ntreta, Maria, Padula, Gilbert D. A., Arcelli, Alessandra, Cammelli, Silvia, Rambaldi, Giuseppe Zanirato, Cilla, Savino, Valentini, Vincenzo, Morganti, Alessio G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283858/
https://www.ncbi.nlm.nih.gov/pubmed/30038390
http://dx.doi.org/10.1038/s41391-018-0064-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283858/
https://www.ncbi.nlm.nih.gov/pubmed/30038390
http://dx.doi.org/10.1038/s41391-018-0064-7

Ejemplares similares